References
- Abyaneh, M. Y., Griffith, R. D., Falto-Aizpurua, L., Nouri, K. (2014). Narrowband ultraviolet B phototherapy in combination with other therapies for vitiligo: Mechanisms and efficacies. J. Eur. Acad. Dermatol. Venereol., 28, 1610–1622.10.1111/jdv.1261925073648
- Alikhan, A., Felste,, L. M., Daly, M., Petronic-Rosic, V. (2011). Vitiligo: A comprehensive overview. Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histpathology, etiology, and work-up. J. Amer. Acad. Dermatol., 65, 473–491.10.1016/j.jaad.2010.11.06121839315
- Brazzeli, V., Prestinari, F. (2005). Useful treatment of vitiligo in 10 children with UV-B-narrow-band (311 nm). Pediatr. Dermatol., 22, 257–261.10.1111/j.1525-1470.2005.22319.x15916579
- Chen, G. Y., Hsu, M. M., Tai, H. K. (2005). Narrow-band UVB treatment of vitiligo in Chinese. J. Dermatol., 10, 793–800.10.1111/j.1346-8138.2005.tb00847.x16361730
- Cui, J., Shen, L. Y., Wang, G. C. (1991). Role of hair follicles in the repigmentation of vitiligo. J. Invest. Dermatol., 97, 410–416.10.1111/1523-1747.ep124809971714927
- Esfandiarpour, I., Ekhlasi, A., Farajzadeh, S., Shamsadini, S. (2009). The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: A double- blind, placebo-controlled clinical trial. J. Dermatol. Treat., 20, 14–18.10.1080/0954663080215505718608735
- Fai, D., Cassano, N., Vena, G. A. (2007). Narrow-band UVB phototherapy combined with tacrolimus ointment in vitiligo: A review of 110 patients. J. Eur. Acad. Dermatol. Venereol., 21, 916–920.10.1111/j.1468-3083.2006.02101.x17659000
- Gawkrodger, D. J., Ormerod, A. D., Shaw, L., Mauri-Sole, I., Whitton, M. E., Watts, M. J. (2008). Guideline for the diagnosis and management of vitiligo. Brit. J. Dermatol., 159, 1051–1076.10.1111/j.1365-2133.2008.08881.x19036036
- Grimes, P. E., Morris, R., Avaniss-Aghajani, E., Soriano, T., Meraz, M., Metzger, A. (2004). Topical tacrolimus therapy for vitiligo: Therapeutic responses and skin messenger RNA expression of proinflammatory cytokines. J. Amer. Acad. Dermatol., 51, 52–61.10.1016/j.jaad.2003.12.03115243524
- Hirobe, T. (2005). Role of keratinocyte-derived factors involved in regulating the proliferation and differentiation of mammalian epidermal melanocytes. Pigment Cell Res., 18, 2–12.10.1111/j.1600-0749.2004.00198.x15649147
- Iannella, G., Greco, A., Didon, D., Didona, B., Granata, G., Manno, A., Pasquariello, B., Magliulo, G. (2016). Vitiligo: Pathogenesis, clinical variants and treatment approaches. Autoimmun. Rev., 15, 335–343.10.1016/j.autrev.2015.12.006
- Kang, H. Y., Choi, Y. M. (2009). FK 506 increases pigmentation and migration of human melanocytes. Brit. J. Dermatol., 155, 1037–1040.10.1111/j.1365-2133.2006.07467.x
- Kanwar, A. J., Dogra, S. (2006). Narrow-band UVB for the treatment of generalized vitiligo in children. Clin. Exp. Dermatol., 45, 63–65.
- Klahan, S., Asawanonda, P. (2009). Topical tacrolimus may enhance repigmentation with targeted narrowband ultraviolet B to treat vitiligo: A randomized, controlled study. Clin. Exp. Dermatol., 34, 1029–1030.10.1111/j.1365-2230.2009.03712.x
- Lan, C. C., Che, G. S., Chiou, M. H., Wu, C. S., Chang, C. H., Yu, H. S. (2005a). FK506 promotes melanocyte and melanoblast growth and creates a favourable milieu for cell migration via keratinocytes: Possible mechanisms of how tacrolimus ointment induces repigmentation in patients with vitiligo. Brit. J. Dermatol., 153 (3), 498–505.10.1111/j.1365-2133.2005.06739.x
- Lan, C. C., Chen, G. S., Chiou, M. H. (2005b). FK 506 promotes melanocyte and melanoblast growth and creates a favourable milieu for cell migration via keratinocytes. Brit. J. Dermatol., 153, 496–505.10.1111/j.1365-2133.2005.06739.x
- Lee, K. Y., Jeon, S. Y., Hong, J. W., Choi, K. W., Lee, C. Y., Choi, S. J., Kim, J. H., Song, K. H., Kim, K. H. (2013). Endothelin-1 enhances the proliferation of normal human melanocytes in a paradoxical manner from the TNF-α-inhibited condition, but tacrolimus promotes exclusively the cellular migration without proliferation: A proposed action mechanism for combination therapy of phototherapy and topical tacrolimus in vitiligo treatment. J. Eur. Acad. Dermatol. Venereol., 27, 609–616.10.1111/j.1468-3083.2012.04498.x
- Lotti, T., Buggiani, G., Troiano, M. (2008). Targeted and combination treatment for vitiligo. Comparative evaluation of different current modalities in 458 subjects. Dermatol. Ther., 21, 20–S26.
- Majid, I. (2010). Does topical tacrolimus ointment enhance the efficacy of narrow-band ultraviolet B therapy in vitiligo? A left-right comparison study. Photodermatol. Photoimmunol. Photomed., 26, 230–234.10.1111/j.1600-0781.2010.00540.x
- Mehrabi, D., Pandya, A. G. (2006). A randomized, placebo-controlled, double-blind trial comparing narrowband UV-B plus placebo in the treatment of generalized vitiligo. Arch. Dermatol., 142, 927–929.10.1001/archderm.142.7.927
- Moretti, S., Spallanzani, A., Amato, L., Hautmann, G., Gallerani, I., Fabiani, M. (2002). New insights into the pathogenesis of vitiligo: Imbalance of epidermal cytokines at sites of lesions. Pigment Cell Res., 15, 87–92.10.1034/j.1600-0749.2002.1o049.x
- Njoo, M., Bos, M. S., Westerhof, W. (2000). Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy. J. Amer. Acad. Dermatol., 42, 245–253.10.1016/S0190-9622(00)90133-6
- Nordal, E. J., Guleng, G. E., Rönnevig, J. R. (2011). Treatment of vitiligo with narrowband-UVB (TL 01) combined with tacrolimus ointment (0.1%) vs. placebo ointment, a randomized right/left double-blind comparative study. J. Eur. Acad. Dermatol. Venereol., 25, 1440–1443.10.1111/j.1468-3083.2011.04002.x21466589
- Ongenae, K., Beelaert, L., van Geel, N., Naeyaert, J. M. (2006). Psychosocial effects of vitiligo. J. Eur. Acad. Dermatol. Venereol., 20, 1–8.10.1111/j.1468-3083.2005.01369.x16405601
- Ponsonby, A. L., Lucas, R. M., van der Mei, I. A. (2005). UVR, vitamin D and three autoimmune diseases — multiple sclerosis, type I diabetes, rheumatoid arthritis. Photochem. Photobiol., 81, 1267–1275.10.1562/2005-02-15-IR-44115971932
- Satyanarayan, H. S., Kanwar, J. A., Parsad, D., Vinay, K. (2013). Efficacy and tolerability of combined treatment with NB-UVB and topical tacrolimus versus NB-UVB alone in patients with vitiligo vulgaris: A randomized intra-individual open comparative trial. Indian J. Dermatol. Venereol. Leprol., 79, 525–527.10.4103/0378-6323.11309123760325
- Seirafi, H., Farnaghi, F., Firooz, A., Vasheghani-Farahani, A., Allirezale, N. S., Dowlati, Y. (2007). Pimecrolimus cream in repigmentation of vitiligo. Dermatology, 214, 253–259.10.1159/00009959217377388
- Senft, D., Ronai, Z. A. (2016). Immunogenic, cellular, and angiogenic drivers of tumour dormancy: A melanoma view. Pigment Cell Melanoma Res., 1, 27–42.10.1111/pcmr.1243226514653
- Sisti, A., Sisti, G., Oranges, C. M (2016). Effectiveness and safety of topical tacrolimus for repigmentation in vitiligo: A comprehensive literature review. An. Bras. Dermatol., 91, 187–195.10.1590/abd1806-4841.20164012486156627192518
- Taieb, A., Alomar, A., Böhm, M., Dell’anna, M. L., De Pase, A., Eleftheriadou, V., Ezzedine, K., Gauthier, Y., Gawkrodger, D. J., Jouary, T. (2013). Guidelines for the management of vitiligo: The European Dermatology Forum consensus. Brit. J. Dermatol., 168, 5–19.10.1111/j.1365-2133.2012.11197.x22860621
- Taieb, A., Picardo, M. (2010). Epidemiology, definitions and classification. In: Vitiligo. Springer, Berlin-Heidelberg, pp. 13–24.10.1007/978-3-540-69361-1_2
- Taieb, A., Picardo, M., VETF Members (2007). The definition and assessment of vitiligo: A consensus report of the Vitiligo European Task Force. Pigment Cell Res., 20, 27–35.10.1111/j.1600-0749.2006.00355.x17250545
- Taieb, A., Picardo, M. (2009). Clinical practice: Vitiligo. New Eng. J. Med., 360, 160–169.10.1056/NEJMcp080438819129529
- Tran, C., Lubbe, J., Sorg, O. (2005). Topical calcineurin inhibitors decrease the production of UVB-induced thymine dimers from hair less mouse epidermis. Dermatology, 211, 341–347.10.1159/00008850516286744
- Westerhof, W., d’Ischia, M. (2007). Vitiligo puzzle: The pieces fall in place. Pigment Cell Res., 20, 345–359.10.1111/j.1600-0749.2007.00399.x17850508
- Whitton, M. E., Pinart, M., Batchelor, J., Lushe, C., Leonardi-Bee, J., González, U. (2010). Interventions for vitiligo. Cochrane Database Syst. Rev., 20 (1), CD003263.10.1002/14651858.CD003263.pub420091542
- Wu, C. S., Yu, C. L., Lan, C. C. E., Yu, H. S. (2004). Narrow-band ultraviolet B stimulates proliferation and migration of cultured melanocytes. Exp. Dermatol., 13, 755–763.10.1111/j.0906-6705.2004.00221.x15560759